跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zotarolimus
首页
药物
Zotarolimus
Zotarolimus
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions of tetrazole derivatives of sirolimus and anti-oxidants
EP 2712867 A1
申请人: ABBOTT LAB
优先权: 2005
CN
EP
US
7 件公开
Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens
US 7357942 B2
申请人: ABBOTT LAB
优先权: 2006
US
4 件公开
Method of treating malignant solid tumors
US 8383671 B1
申请人: ABBOTT CARDIOVASCULAR SYSTEMS
优先权: 2009
US
3 件公开
COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS USING MEDICAL DEVICES FOR LONG-TERM EFFICACY
US 2006198867 A1
申请人: ABBOTT LAB
优先权: 2006
US
WO
2 件公开
EP 3138531 A1
申请人: ABBOTT LAB
优先权: 2005
EP
PARENTERAL FORMULATION MATERIALS AND METHODS FOR 40-O-CYCLIC HYDROCARBON ESTERS AND RELATED STRUCTURES
WO 2019162048 A1
申请人: BIOTRONIK AG
优先权: 2018
CN
WO
2 件公开
Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens
US 7378105 B2
申请人: ABBOTT LAB
优先权: 2006
US
2 件公开
Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
US 8257726 B2
申请人: BURKE SANDRA E
优先权: 2006
US
2 件公开
WO 2007046935 A3
申请人: ABBOTT LAB
优先权: 2005
WO
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US 8435550 B2
申请人: CHENG JIN
优先权: 2008
US
2 件公开
Coatings including dexamethasone derivatives and analogs and olimus drugs
US 8092822 B2
申请人: PACETTI STEPHEN D
优先权: 2008
US
2 件公开
Medical device with crystalline drug coating
US 9056152 B2
申请人: KANGAS STEVE
优先权: 2011
US
2 件公开
第 1 / 2 页
上一页
下一页
药物
反馈